Document Detail


A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution.
MedLine Citation:
PMID:  19886316     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Encapsulating peritoneal sclerosis (EPS) is an intestinal obstruction syndrome in which peritoneal deterioration and intraperitoneal inflammation result in intestinal adhesions, which are covered with a fibrin capsule and which cause bowel obstruction. Here, we report the case of a patient with EPS suspected to result from the use of icodextrin peritoneal solution. In this patient, peritoneal permeability to high molecular weight solutes and effluent interleukin-6 (IL-6) levels increased after initiation on-to icodextrin solution. The patient developed symptoms of intestinal obstruction accompanied by intestinal edema 30 months after the start of icodextrin and after a peritoneal dialysis (PD) duration of 78 months. He was then diagnosed as being in a pre-EPS state. The use of icodextrin solution was discontinued, and the symptoms of intestinal obstruction improved after corticosteroid administration. Subsequently, he was managed on a combination of PD using glucose solution low in glucose degradation products and of twice-weekly hemodialysis, but he showed enhanced peritoneal permeability and increases in effluent IL-6. After a PD period of 98 months, severe symptoms of intestinal obstruction developed, and enterolysis was performed. The degeneration of the intestinal wall itself was slight, and the adhesions between the capsule and intestinal surface could be readily removed. In this patient, the degree of peritoneal deterioration and capsule formation differed from that of typical EPS. These findings suggest the promotion of capsule formation by icodextrin solution and the involvement of certain inflammatory reactions.
Authors:
Hideki Kawanishi; Sadanori Shintaku; Masayuki Shishida; Misaki Morrishi; Shinichiro Tsuchiya; Kiyohiko Dohi
Related Documents :
8629636 - Sclerosing peritonitis occurring in a hemodialysis patient.
6635946 - Peritoneal lavage: a useful diagnostic adjunct for peritonitis.
10898046 - Phenotypic alterations of recruited eosinophils in peritoneal fluid eosinophilia.
9932656 - Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on contin...
24130266 - Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (ve...
1579226 - The middle latency auditory evoked potential may be abnormal in dementia.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Advances in peritoneal dialysis. Conference on Peritoneal Dialysis     Volume:  25     ISSN:  1197-8554     ISO Abbreviation:  Adv Perit Dial     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-05     Completed Date:  2009-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9104803     Medline TA:  Adv Perit Dial     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  45-9     Citation Subset:  IM    
Affiliation:
Tsuchiya General Hospital, Hiroshima, Japan. h-kawanishi@tsuchiya-hp.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Glucans / adverse effects*
Glucose / adverse effects*
Hemodialysis Solutions / adverse effects*
Humans
Interleukin-6 / metabolism
Intestinal Obstruction / etiology
Male
Middle Aged
Peritoneal Dialysis*
Peritoneal Fibrosis / chemically induced*,  diagnosis,  metabolism,  therapy
Peritoneum / metabolism
Permeability / drug effects
Chemical
Reg. No./Substance:
0/Glucans; 0/Hemodialysis Solutions; 0/Interleukin-6; 0/icodextrin; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Peritoneal dialysis patients with high effluent fibrin degradation products.
Next Document:  Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory ...